Alaunos Therapeutics | ZIOP - Cash And Equivalent


Alaunos Therapeutics reported $1.94M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Amgen USD 9.13B 316M Dec/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Baxter International USD 1.97B 240M Dec/2025
Biogen USD 3.01B 854.3M Dec/2025
Bioline Rx USD 7.91M 725K Sep/2025
Bristol-Myers Squibb USD 10.21B 5.52B Dec/2025
Celltrion KRW 29.65B 799.42B Jun/2025
Corcept Therapeutics USD 120.49M 4.64M Dec/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Curis USD 10.14M 10.14M Jun/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Gilead Sciences USD 7.33B 2.19B Sep/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
Incyte USD 3.58B 650.78M Dec/2025
Intrexon USD 9.34M 1.77M Jun/2024
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
J&J USD 19.71B 1.48B Dec/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Karyopharm Therapeutics USD 37.67M 1.05M Sep/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Merck USD 18.17B 10.16B Sep/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Novartis USD 9.56B 2.9B Sep/2025
Organigram Holdings CAD 28.2M 7.68M Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
PTC Therapeutics USD 984.65M 312.03M Dec/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Regeneron Pharmaceuticals USD 18.87B 16.36B Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
TG Therapeutics USD 178.32M 100.54M Sep/2025
Tilray USD 264.83M 43.16M Jun/2025
Verastem USD 117.57M 28.75M Mar/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025